Fatemeh Chalabianloo

9PUBLICATIONS
12CO-AUTHORS
Mental health servicesPredictive and prognostic markersPharmacogenomicsMetabolic medicineToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
Strengthening global responses to stimulant use disorders: From policy commitments to evidence-based treatment innovation.

|May 07, 2026
Association between thyroidea function and opioid agonist therapy: a prospective cohort study from Norway.

|Oct 21, 2025
Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: a study protocol for the multicentre double blind randomised controlled trial ATLAS4Dependence.

Fatemeh Chalabianloo, Lars T Fadnes, Jon Mordal

|Jan 03, 2025
Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BAR.

Fatemeh Chalabianloo, Lars Thore Fadnes, Jörg Assmus

|Nov 28, 2024
Methadone metabolism and cytochrome P450 polymorphisms: a systematic review and meta-analysis.

Seenae Eum, Nicholas P Vernacchia, Nia Doughty

|Dec 21, 2023
Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications.

Fatemeh Chalabianloo, Lars Thore Fadnes, Kjell Arne Johansson

Pageof 2

Frequent Collaborators

2 joint publications

Lars Thore Fadnes

2 joint publications

Kjell Arne Johansson

1 joint publications

Gudrun Høiseth

1 joint publications

Seenae Eum